Sybron Dental Specialties, Inc. (the "Company") announced today the completion of its previously announced tender offer and consent solicitation (the "Offer") for any and all of its outstanding $150,000,000 aggregate principal amount of 8- 1/8% Senior Subordinated Notes due 2012 (CUSIP No. 871142AB1) (the "Notes") pursuant to the Offer to Purchase and Consent Solicitation Statement dated May 23, 2006.

The offer expired at 12:00 midnight EDT, on Tuesday, June 20, 2006, with $148,417,000 in aggregate principal amount of Notes (approximately 98.9% of outstanding Notes) tendered and accepted for purchase under the terms of the Offer.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any Notes or other securities, nor shall there be any sale of any Notes or other securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This announcement is also not an offer to purchase, a solicitation of an offer to purchase or a solicitation of consents with respect to any Notes or other securities. The tender offer and consent solicitation are being made solely by the Offer to Purchase and Consent Solicitation Statement dated May 23, 2006.

BUSINESS DESCRIPTION

Sybron Dental Specialties, a subsidiary of Danaher Corporation, is a leading manufacturer of both a broad range of value-added products for the dental profession, including the specialty markets of orthodontics, endodontics and implantology, and a variety of infection prevention products for use by the medical profession.

SOURCE: Sybron Dental Specialties, Inc.